{"nct_id":"NCT01231503","title":"Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2011-01-13","start_date_type":"ACTUAL","primary_completion_date":"2014-04-30","primary_completion_date_type":"ACTUAL","completion_date":"2014-12-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}